KB
OGN icon

Kimelman & Baird’s Organon & Co OGN Stock Holding History

Kimelman & Baird’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.7K Hold
450
– – ﹤0.01% 229
2025
Q4 		$3.23K Sell
450
-2
-0.4% -$16 ﹤0.01% 227
2025
Q3 		$4.83K Hold
452
– – ﹤0.01% 248
2025
Q2 		$4.38K Hold
452
– – ﹤0.01% 277
2025
Q1 		$6.73K Hold
452
– – ﹤0.01% 272
2024
Q4 		$6.74K Hold
452
– – ﹤0.01% 275
2024
Q3 		$8.65K Hold
452
– – ﹤0.01% 277
2024
Q2 		$9.36K Buy
+452
New +$8.98K ﹤0.01% 275
2021
Q2 		$527K Buy
+17,408
New +$573K 0.05% 79

Other funds holding OGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KBG
Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return

Kimelman & Baird's OGN Position: Q1 2026 in Review

Kimelman & Baird held its Organon & Co (OGN) position steady in Q1 2026 at 450 shares worth $2.7K. The position accounts for ﹤0.01% of the portfolio, ranked #229.

Kimelman & Baird first reported a position in OGN in Q2 2021 and has held it in 9 quarters since. The position peaked at $527K in Q2 2021. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Kimelman & Baird held 450 shares of Organon & Co worth $2.7K as of Q1 2026.
  • Kimelman & Baird left its Organon & Co share count unchanged in Q1 2026.
  • Organon & Co made up ﹤0.01% of Kimelman & Baird's portfolio in Q1 2026, its #229 holding.
  • Kimelman & Baird first reported a position in Organon & Co in Q2 2021 and has held it in 9 quarters since.
  • Kimelman & Baird's Organon & Co position peaked at $527K in Q2 2021.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Kimelman & Baird's 13F filing for Q1 2026, filed 13 May 2026.